| Literature DB >> 2249204 |
Abstract
MS-Contin (Purdue-Fredrick, Norwalk, CT) is a controlled-release preparation of morphine sulfate that has demonstrated efficacy in the management of chronic cancer pain problems. It has recently come to the attention of the authors that MS-Contin represents a potential source of opioid abuse through the extraction and intravenous injection of the morphine from this preparation. The authors describe a simple aqueous extraction method that was used to quantitatively determine the extent to which morphine could be obtained from MS-Contin tablets.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2249204 DOI: 10.1002/1097-0142(19901215)66:12<2642::aid-cncr2820661229>3.0.co;2-b
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860